• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 2012-2016 年住院产妇长效可逆避孕和绝育率的变化。

Changes in Rates of Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the USA, 2012-2016.

机构信息

Department of Obstetrics and Gynecology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA.

出版信息

Matern Child Health J. 2021 Oct;25(10):1562-1573. doi: 10.1007/s10995-021-03152-0. Epub 2021 May 10.

DOI:10.1007/s10995-021-03152-0
PMID:33970416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8449803/
Abstract

OBJECTIVES

To examine recent rates of long-acting and permanent methods (LAPM) of contraception use during delivery hospitalization and correlates of their use.

METHODS

A retrospective cohort study utilizing the 2012-2016 National Inpatient Sample of hospitalizations in the United States of America. The International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes were used to identify deliveries, inpatient long-acting reversible contraception (IPP LARC), and postpartum tubal ligation (PPTL). We conducted univariable and multivariable logistic regression to examine associations between demographic, clinical, hospital and geographical characteristics with likelihood of LAPM including IPP LARC and PPTL.

RESULTS

Our sample included 3,642,328 unweighted deliveries. The rate of IPP LARC increased from 34.6 to 54.9 per 10,000 deliveries (58.7%), while the rate of PPTL utilization decreased from 719.5 to 671.8 per 10,000 deliveries (6.6%) over the study period. In multivariable analysis of LAPM utilization versus neither, cesarean delivery (aOR 7.25, 95% CI 7.08-7.43) was associated with greater utilization. Native American (aOR 4.01, 95% CI 2.91-5.53) race was associated with increased use of IPP LARC compared to a non-long-acting method of contraception. Age between 18 and 29 years (aOR 6.21, 95% CI 5.42-7.11) was associated with greater use of IPP LARC versus PPTL. Delivering in a rural hospital ((aOR 0.09, 95% CI 0.06-0.12) and cesarean delivery (aOR 0.09, 95% CI 0.06-0.12) were associated with greater use PPTL versus IPP LARC.

CONCLUSIONS

The IPP LARC rate remains at less than 10% the PPTL rates in our study timeframe. The demonstrated variation in uptake of highly effective methods of contraception inpatient after delivery offer possible opportunities for better understanding and improvement in access.

摘要

目的

调查美国分娩住院期间长效和永久性避孕方法(LAPM)的近期使用率及其使用的相关因素。

方法

本研究使用了美国 2012-2016 年全国住院患者抽样调查的回顾性队列研究。采用国际疾病分类第 9 版和第 10 版临床修正版代码来识别分娩、院内长效可逆避孕(IPP LARC)和产后输卵管结扎(PPTL)。我们进行了单变量和多变量逻辑回归分析,以研究人口统计学、临床、医院和地理特征与 LAPM(包括 IPP LARC 和 PPTL)使用的可能性之间的关联。

结果

我们的样本包括 3642328 例未加权分娩。IPP LARC 的使用率从每 10000 例 34.6 例增加到 54.9 例(58.7%),而 PPTL 的使用率从每 10000 例 719.5 例下降到 671.8 例(6.6%)。在 LAPM 使用率与非 LAPM 使用率的多变量分析中,剖宫产(aOR 7.25,95%CI 7.08-7.43)与更高的使用率相关。与非长效避孕方法相比,美国原住民(aOR 4.01,95%CI 2.91-5.53)种族与 IPP LARC 的使用增加相关。18-29 岁年龄组(aOR 6.21,95%CI 5.42-7.11)与 IPP LARC 的使用增加相关,而非 PPTL。在农村医院分娩(aOR 0.09,95%CI 0.06-0.12)和剖宫产(aOR 0.09,95%CI 0.06-0.12)与 IPP LARC 相比,PPTL 的使用率更高。

结论

在我们的研究时间段内,IPP LARC 的使用率仍然不到 PPTL 使用率的 10%。分娩后住院期间高效避孕方法的使用率存在差异,这为更好地理解和改善获取途径提供了可能的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e9/8449803/ae172fb46b30/nihms-1725806-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e9/8449803/9507caae8b32/nihms-1725806-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e9/8449803/ae172fb46b30/nihms-1725806-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e9/8449803/9507caae8b32/nihms-1725806-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e9/8449803/ae172fb46b30/nihms-1725806-f0002.jpg

相似文献

1
Changes in Rates of Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the USA, 2012-2016.美国 2012-2016 年住院产妇长效可逆避孕和绝育率的变化。
Matern Child Health J. 2021 Oct;25(10):1562-1573. doi: 10.1007/s10995-021-03152-0. Epub 2021 May 10.
2
Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.2008 - 2013年美国住院产后长效可逆避孕与绝育情况
Obstet Gynecol. 2017 Jun;129(6):1078-1085. doi: 10.1097/AOG.0000000000001970.
3
Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible, and permanent contraception.分析获得即刻产后、长效、可逆和永久性避孕措施的种族和民族差异。
Contraception. 2024 Oct;138:110512. doi: 10.1016/j.contraception.2024.110512. Epub 2024 Jun 7.
4
Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.美国住院输卵管结扎和长效可逆避孕措施发病率的最新情况。
Am J Obstet Gynecol. 2022 Sep;227(3):477.e1-477.e7. doi: 10.1016/j.ajog.2022.05.021. Epub 2022 May 13.
5
Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.桥接避孕在产后长效可逆避孕和绝育完成率中的作用。
Obstet Gynecol. 2018 Sep;132(3):583-590. doi: 10.1097/AOG.0000000000002803.
6
Tennessee Medicaid patient immediate postpartum long-acting reversible contraception utilization.田纳西州医疗补助计划患者产后即时长效可逆避孕措施的使用情况
Contraception. 2025 Feb;142:110721. doi: 10.1016/j.contraception.2024.110721. Epub 2024 Oct 1.
7
Timing of postpartum long acting, reversible contraception was not associated with 12-month removal rates in a large Medicaid sample.在一个大型医疗补助样本中,产后长效可逆避孕的时机与12个月的取出率无关。
Contraception. 2022 Sep;113:49-56. doi: 10.1016/j.contraception.2022.03.018. Epub 2022 Apr 1.
8
Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.即刻产后和流产后长效可逆避孕措施在青少年中的可接受性:系统评价。
Acta Obstet Gynecol Scand. 2021 Apr;100(4):629-640. doi: 10.1111/aogs.14129. Epub 2021 Mar 9.
9
Association of Opioid Use Disorder and Provision of Highly Effective Inpatient Postpartum Contraception.阿片类物质使用障碍与高效住院产后避孕措施的提供之间的关联
Open Access J Contracept. 2023 Jun 20;14:95-102. doi: 10.2147/OAJC.S411092. eCollection 2023.
10
Provision of Immediate Postpartum Long-Acting Reversible Contraceptives Before and After Wisconsin Medicaid's Payment Change.威斯康星州医疗补助计划支付方式改变前后立即提供产后长效可逆避孕措施。
Womens Health Issues. 2021 Jul-Aug;31(4):317-323. doi: 10.1016/j.whi.2021.02.009. Epub 2021 Apr 10.

引用本文的文献

1
Postpartum contraceptive use after vaginal and caesarean birth in Nigeria: a nationwide population-based analysis.尼日利亚阴道分娩和剖宫产术后的产后避孕措施:一项基于全国人口的分析。
BMJ Public Health. 2025 Jul 31;3(2):e001998. doi: 10.1136/bmjph-2024-001998. eCollection 2025.
2
Measuring abortion in claims data: What is the state of the science?在理赔数据中衡量堕胎情况:科学现状如何?
Contraception. 2025 Feb;142:110750. doi: 10.1016/j.contraception.2024.110750. Epub 2024 Nov 15.
3
Contraception and sterilization selection at delivery among pregnant patients with malignancy.

本文引用的文献

1
Association of race and ethnicity with postpartum contraceptive method choice, receipt, and subsequent pregnancy.种族和民族与产后避孕方法选择、使用和随后怀孕的关系。
BMC Womens Health. 2021 Jan 7;21(1):17. doi: 10.1186/s12905-020-01162-8.
2
Association between neighborhood disadvantage and fulfillment of desired postpartum sterilization.社区劣势与期望产后绝育的实现之间的关联。
BMC Public Health. 2020 Sep 22;20(1):1440. doi: 10.1186/s12889-020-09540-5.
3
The Association of Public Insurance with Postpartum Contraception Preference and Provision.
分娩孕妇恶性肿瘤避孕及绝育选择。
Acta Obstet Gynecol Scand. 2024 Apr;103(4):695-706. doi: 10.1111/aogs.14654. Epub 2023 Aug 14.
4
Association of Opioid Use Disorder and Provision of Highly Effective Inpatient Postpartum Contraception.阿片类物质使用障碍与高效住院产后避孕措施的提供之间的关联
Open Access J Contracept. 2023 Jun 20;14:95-102. doi: 10.2147/OAJC.S411092. eCollection 2023.
公共保险与产后避孕偏好及供应的关联
Open Access J Contracept. 2019 Dec 19;10:103-110. doi: 10.2147/OAJC.S231196. eCollection 2019.
4
Desired Sterilization Procedure at the Time of Cesarean Delivery According to Insurance Status.根据保险状况在剖宫产时选择的绝育手术。
Obstet Gynecol. 2019 Dec;134(6):1171-1177. doi: 10.1097/AOG.0000000000003552.
5
Obstetric Care Consensus No. 8: Interpregnancy Care.产科保健共识第 8 号:孕间保健。
Obstet Gynecol. 2019 Jan;133(1):e51-e72. doi: 10.1097/AOG.0000000000003025.
6
Impact of training level on postplacental levonorgestrel 52 mg intrauterine device expulsion.培训水平对产后左炔诺孕酮 52mg 宫内节育器脱落的影响。
Contraception. 2019 Feb;99(2):94-97. doi: 10.1016/j.contraception.2018.11.003. Epub 2018 Nov 16.
7
Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.产后放置宫内节育器后脱落:系统评价和荟萃分析。
Obstet Gynecol. 2018 Oct;132(4):895-905. doi: 10.1097/AOG.0000000000002822.
8
Medicaid and receipt of interval postpartum long-acting reversible contraception.医疗补助计划与产后长效可逆避孕措施的获得。
Contraception. 2019 Jan;99(1):32-35. doi: 10.1016/j.contraception.2018.08.017. Epub 2018 Sep 5.
9
Obstetrician-gynecologists' counseling regarding postpartum sterilization.妇产科医生关于产后绝育的咨询。
Int J Womens Health. 2018 Aug 13;10:425-429. doi: 10.2147/IJWH.S169674. eCollection 2018.
10
Surgical sterilization among US men and women with employer-based insurance: A claims data analysis.美国有雇主保险的男性和女性的手术绝育:一项索赔数据分析。
Contraception. 2018 Sep;98(3):247-251. doi: 10.1016/j.contraception.2018.05.011. Epub 2018 May 18.